Antitumor activity of a PPARdelta antagonist.
Vascular Biology Center, Division of Hematology Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.Cancer biology & therapy (Impact Factor: 3.29). 08/2009; 8(13):1262-4. DOI: 10.4161/cbt.8.13.9061
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.